How The Parts Add Up: VIOO Headed For $118
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 23 2025
0mins
Source: NASDAQ.COM
ETF Analysis: The Vanguard S&P Small-Cap 600 ETF (VIOO) has an implied analyst target price of $118.23, indicating a potential upside of 20.32% from its current trading price of $98.27.
Stock Performance Insights: Notable underlying holdings such as Arrowhead Pharmaceuticals, Dynavax Technologies, and Simulations Plus show significant upside potential based on analyst targets, raising questions about the validity and optimism of these forecasts.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SLP?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SLP
Wall Street analysts forecast SLP stock price to rise
5 Analyst Rating
2 Buy
3 Hold
0 Sell
Moderate Buy
Current: 18.350
Low
19.00
Averages
19.00
High
19.00
Current: 18.350
Low
19.00
Averages
19.00
High
19.00
About SLP
Simulations Plus, Inc. specializes in model-informed and artificial intelligence (AI)-accelerated drug development. The Company helps its clients by accelerating the discovery, development, and commercialization of pharmaceuticals and other products through science-based software and consulting solutions. The Company’s segments include Software and Services. The Company's Software segment supports pharmaceutical research, development, and commercialization through simulation, modeling, and AI-driven prediction. Its main products include GastroPlus, ADMET Predictor, MonolixSuite, and others for disease modeling and training, as well as Pro-ficiency for clinical operations. Its Services segment includes advanced consulting services across the entire drug development lifecycle. Its scientists and engineers specialize in drug discovery, pharmacokinetics, pharmacodynamics, drug modeling, clinical trial data analysis, regulatory strategy, and medical communications.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Investigation Background: Halper Sadeh LLC is investigating Arcosa, Inc., Simulations Plus, Inc., AstroNova, Inc., and Fathom Holdings Inc. for potential violations of federal securities laws and fiduciary duties to shareholders, with transaction prices at $150.00, $18.50, $29.00, and 0.2236 shares of Bed Bath & Beyond stock respectively.
- Shareholder Rights Protection: The law firm encourages shareholders to contact them to discuss their rights and options, committing to handle matters on a contingent fee basis, which underscores their focus on safeguarding shareholder interests.
- Potential Financial Benefits: The investigation highlights that insiders may receive substantial financial benefits not available to ordinary shareholders, which could impact the fairness and transparency of the transactions, raising concerns among shareholders regarding the terms of the deals.
- Possibility of Legal Action: Halper Sadeh LLC may seek increased consideration, additional disclosures, or other relief measures to protect shareholders' rights, indicating their proactive involvement in addressing securities fraud and corporate misconduct.
See More
- Investigation Background: Johnson Fistel, PLLP is investigating potential securities law violations by Simulations Plus, Inc., focusing on whether the company made false or misleading statements regarding its financial outlook, reporting practices, and internal controls, which could significantly impact investors.
- Revenue Guidance Cut: On June 11, 2025, Simulations Plus revised its full-year fiscal 2025 revenue guidance down from $90 million to $93 million to a range of $76 million to $80 million, primarily due to market uncertainties affecting pharmaceutical and biotechnology clients, leading to budget cuts and project cancellations.
- Stock Price Volatility: Following the guidance cut, Simulations Plus's stock plummeted over 24%, from $26.44 per share to $20.05 per share; additionally, the company reported a net loss of $67.3 million in its third-quarter results on July 14, 2025, causing the stock to drop nearly 26% again.
- Audit Firm Dismissal: On July 15, 2025, Simulations Plus dismissed Grant Thornton LLP as its independent registered public accounting firm due to unresolved matters related to financial reporting, which further eroded market confidence in the company's internal controls.
See More
- Investigation Background: Johnson Fistel, PLLP is investigating potential securities law violations by Simulations Plus, Inc., focusing on misleading statements regarding the company's financial outlook, reporting practices, and internal controls, which could significantly impact investors.
- Revenue Guidance Cut: On June 11, 2025, Simulations Plus revised its fiscal 2025 revenue guidance down to $76 million to $80 million, primarily due to market uncertainties affecting pharmaceutical and biotechnology clients, leading to a stock price drop of over 24%.
- Significant Financial Loss: On July 14, 2025, Simulations Plus reported a net loss of $67.3 million for the third quarter, translating to a loss of $3.35 per diluted share, which included a $77.2 million non-cash impairment charge, indicating severe deterioration in financial health.
- Audit Firm Dismissal: Simulations Plus dismissed Grant Thornton LLP as its independent auditor, citing unresolved issues related to financial reporting, which contributed to a nearly 26% decline in stock price, raising concerns about corporate governance and financial transparency.
See More
- Investigation Background: Johnson Fistel, PLLP is investigating potential securities law violations by Simulations Plus, Inc., focusing on whether the company made false or misleading statements regarding its financial outlook, reporting practices, and internal controls, which could significantly impact investors.
- Revenue Guidance Cut: On June 11, 2025, Simulations Plus revised its full-year fiscal 2025 revenue guidance down to $76 million to $80 million from $90 million to $93 million, primarily due to market uncertainties affecting pharmaceutical and biotechnology clients, leading to budget cuts and project cancellations.
- Stock Price Volatility: Following the revenue guidance cut, Simulations Plus's stock plummeted over 24%, from $26.44 per share to $20.05 per share; subsequently, on July 14, 2025, after reporting a net loss of $67.3 million, the stock fell nearly 26% again.
- Audit Firm Dismissal: Simulations Plus disclosed on July 14, 2025, that it had dismissed Grant Thornton LLP as its independent auditor due to unresolved issues related to financial reporting and internal controls, raising further concerns among investors about the company's financial integrity.
See More
- Investigation Focus: Halper Sadeh LLC is investigating companies including Arcosa, Inc. (NYSE: ACA), Open Lending Corporation (NASDAQ: LPRO), Simulations Plus, Inc. (NASDAQ: SLP), and AstroNova, Inc. (NASDAQ: ALOT) for potential violations of federal securities laws and breaches of fiduciary duties, which may adversely affect shareholder rights.
- Transaction Details: Arcosa's sale price is set at $150.00 per share, Open Lending at $3.15 per share, Simulations Plus at $18.50 per share, and AstroNova at $29.00 per share, raising concerns that these prices may not reflect the true value of the companies, potentially harming shareholder interests.
- Shareholder Rights Protection: Halper Sadeh LLC encourages shareholders to contact them to discuss their rights and options at no cost, indicating the firm's commitment to providing legal support to ensure shareholder interests are protected.
- Legal Fee Arrangement: The firm operates on a contingency fee basis, meaning shareholders will not incur legal fees unless the case is successful, which reduces financial risk for shareholders and enhances their willingness to seek legal recourse.
See More
- Shareholder Rights Investigation: Halper Sadeh LLC is investigating potential securities law violations involving AstroNova, Inc. and Simulations Plus, Inc., with the former being sold for $29.00 per share to Arcline Investment Management and the latter for $18.50 per share to Altaris, LLC, which may impact shareholder rights and options.
- Merger Transaction Review: The merger between Olin Corporation and Huntsman Corporation will result in Olin shareholders owning approximately 54.5% of the combined entity, and Halper Sadeh LLC may seek increased compensation and additional disclosures to ensure shareholder rights are protected.
- Legal Fee Arrangement: Halper Sadeh LLC offers legal services on a contingency fee basis, meaning shareholders will not incur any out-of-pocket legal fees when addressing related matters, thereby reducing the financial burden on shareholders and encouraging them to assert their rights.
- Global Investor Support: The firm represents investors worldwide, focusing on combating securities fraud and corporate misconduct, having previously recovered millions of dollars for defrauded investors, demonstrating its expertise and influence in protecting investor rights.
See More







